$ARCC

ARES CAPITAL CORPORATION PRICES PUBLIC OFFERING OF $750 MILLION 6.250% UNSECURED NOTES DUE 2033

Ares Capital Corp (ARCC) priced a $750M public offering of 6.250% unsecured notes due 2033. The notes may be redeemed early at par plus a premium. Proceeds will repay existing debt, with potential reborrowing for general corporate purposes. The offering is expected to close on September 15, 2026.

Original reporting
Published Sep 8, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 9:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ARES CAPITAL CORPORATION PRICES PUBLIC OFFERING OF $750 MILLION 6.250% UNSECURED NOTES DUE 2033 — source image
Decision brief

The 30-second read

$ARCCNeutralMed
01

Why it matters

The $750 M note issuance will be used to repay existing debt and may fund new investments, influencing the company's leverage ratios and earnings outlook.

02

Market read

Primary capital raise for a large BDC; relevant for fixed‑income and equity investors tracking balance‑sheet health.

03

What to watch

Potential covenant restrictions or redemption features could affect future financing flexibility.

Relevance 9/10Novelty 9/10Timing: announcement day

Background

Ares Capital is the largest publicly traded business development company (BDC) in the US, regularly accessing capital markets for debt financing.

Company-level read

Ticker impact

$ARCCNeutralHigh confidence
Context

Ares Capital Corporation announced pricing of a $750 million 6.250% unsecured note offering due 2033, a fresh capital raise.

Expected impact

Potential modest upside as the market views the raise as a positive liquidity event, but price may stay flat pending pricing details.

Evidence & confidence

Large‑scale primary offering is material news; investors will reassess balance‑sheet strength and yield expectations.

Market effects

Adds to overall BDC financing activity, may set a pricing benchmark for peer debt offerings.

US specialty finance sector sees fresh capital supply, modestly supportive for similar issuers.

Limited to US BDC market; no direct global macro effect.

Counterpoint

If the notes are priced at a higher yield than peers, the raise could signal credit concerns, pressuring the stock.

Key entities

  • Ares Capital Corporation

    US‑listed BDC issuing the notes.

  • BofA Securities

    Joint book‑running manager for the offering.

Related articles

$ARCCMed

Ares Leads $2.2 Billion Healthcare Loan

Ares Management Corp. is leading a $2.2 billion loan to MedImpact Holding Inc. to finance its acquisition of Medical Card System, Inc. The second-lien loan may pay at least 8% over the baseline rate. Ares manages $671 billion in assets and recently reported $708 billion in non-accruing loans. MedImpact serves 20 million customers and processes $40 billion in pharmacy transactions annually.

$ARCCMed

Ares Capital Q2 Earnings Call Highlights

Management expects industry credit conditions to continue normalizing toward longer-term averages, though it said performance differences among managers have widened. Schnabel said Ares Capital added four investments to non-accrual during the quarter, but the companies were in unrelated businesses and did not indicate a sector-specific trend.

$ARCCMed

ARES CAPITAL CORPORATION ANNOUNCES JUNE 30, 2026 FINANCIAL RESULTS

ARES CAPITAL CORP (ARCC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ARES CAPITAL CORPORATION ANNOUNCES JUNE 30, 2026 FINANCIAL RESULTS AND DECLARES THIRD QUARTER 2026 DIVIDEND OF $0.48 PER SHARE DIVIDEND DECLARATIONS New York, NY — July 29, 2026 — Ares Capital Corporation (“Ares Capital”) (NASDAQ: ARCC) announced that its Board of Di